ConductScience.org, home

Paper36958337

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.

Richard J and 18 others. Cell Chem Biol, 2023. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120. Papers, record 36958337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.
PubMed
Journal
Cell Chem Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
2.99
iCite
Revised in PubMed
2024-05-19
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richard JJonathan
2Prévost JJérémie
3Bourassa CCatherine
4Brassard NNathalie
5Boutin MMarianne
6Benlarbi MMehdi
7Goyette GGuillaume
8Medjahed HHalima
9Gendron-Lepage GGabrielle
10Gaudette FFleur
11Chen HCHung-Ching
12Tolbert WDWilliam D
13Smith AB 3rdAmos B
14Pazgier MMarzena
15Dubé MMathieu
16Clark AAndrew
17Mothes WWalther
18Kaufmann DEDaniel E
19Finzi AAndrés

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV-1Major topic
CD4-Positive T-Lymphocytes
Down-Regulation
HIV Envelope Protein gp120
Cytokines

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI148379NIAID NIH HHSUnited StatesR01AI148379PubMed and NIHNIH RePORTER
P01 AI150471NIAID NIH HHSUnited StatesP01AI150471PubMed and NIHNIH RePORTER
R01 AI129769NIAID NIH HHSUnited StatesR01AI129769PubMed and NIHNIH RePORTER
R01 AI150322NIAID NIH HHSUnited StatesR01AI150322PubMed and NIHNIH RePORTER
P01 GM056550NIGMS NIH HHSUnited StatesP01GM056550PubMedNIH RePORTER
R01AI174908NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07030920Reducing Systemic Inflammation in People on Antiretroviral TherapyBackground

Source ClinicalTrials.gov

Download CSV of trials

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129162799Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.Nat Commun2017https://conductscience.org/library/papers/29162799PubMed
212951026Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits.Virology2003https://conductscience.org/library/papers/12951026PubMed
329162391Impact of HIV-1 Envelope Conformation on ADCC Responses.Trends Microbiol2018https://conductscience.org/library/papers/29162391PubMed
426575148Residual inflammation and viral reservoirs: alliance against an HIV cure.Curr Opin HIV AIDS2016https://conductscience.org/library/papers/26575148PubMed
525298114Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions.Science2014https://conductscience.org/library/papers/25298114PubMed
69110072gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: an immunoelectron microscopic study.AIDS1997https://conductscience.org/library/papers/9110072PubMed
724516533Slow turnover of HIV-1 receptors on quiescent CD4+ T cells causes prolonged surface retention of gp120 immune complexes in vivo.PLoS One2014https://conductscience.org/library/papers/24516533PubMed
829561264HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations.Elife2018https://conductscience.org/library/papers/29561264PubMed
923886064Residual immune dysregulation syndrome in treated HIV infection.Adv Immunol2013https://conductscience.org/library/papers/23886064PubMed
1021762802HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.J Mol Biol2011https://conductscience.org/library/papers/21762802PubMed
1129394935Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs.Retrovirology2018https://conductscience.org/library/papers/29394935PubMed
1225174000A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.Nat Chem Biol2014https://conductscience.org/library/papers/25174000PubMed
1319231994HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease.J Infect Dis2009https://conductscience.org/library/papers/19231994PubMed
1421471235Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.J Virol2011https://conductscience.org/library/papers/21471235PubMed
1532817216Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.J Virol2020https://conductscience.org/library/papers/32817216PubMed
1628100618Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.J Virol2017https://conductscience.org/library/papers/28100618PubMed
1724128669Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068.J Antimicrob Chemother2014https://conductscience.org/library/papers/24128669PubMed
1833013157Development of an Effective Scalable Enantioselective Synthesis of the HIV-1 Entry Inhibitor BNM-III-170 as the Bis-Trifluoroacetate Salt.Org Process Res Dev2019https://conductscience.org/library/papers/33013157PubMed
1918842730
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
J Virol2008https://conductscience.org/library/papers/18842730PubMed
2019698075HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection.J Infect Dis2009https://conductscience.org/library/papers/19698075PubMed

See all 91 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42728469Impact of Fostemsavir in Individuals with Multidrug-Resistant HIV-1, Stratified by Baseline Viral Load.Infect Dis Ther2026https://conductscience.org/library/papers/42728469PubMed
42655632HIV-1 Env Heterogeneity: Cleavage, Trafficking, and Antigenic Consequences for Virions and Infected Cells.Viruses2026https://conductscience.org/library/papers/42655632PubMed
42322610Comprehensive mapping of the virus and host factors that guide the paths of HIV-1 escape from a therapeutic.Cell Rep2026https://conductscience.org/library/papers/42322610PubMed
42317333Research progress on HIV-1 structural proteins and antiviral therapies.Front Immunol2026https://conductscience.org/library/papers/42317333PubMed
41639021Immune non-response despite effective antiretroviral therapy in people living with HIV: A review of potential mechanisms, biomarkers and therapeutic approaches.HIV Med2026https://conductscience.org/library/papers/41639021PubMed
41600811Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill.Viruses2025https://conductscience.org/library/papers/41600811PubMed
41497656Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic.bioRxiv2025https://conductscience.org/library/papers/41497656PubMed
41201241Highly efficient production of HIV-1AD8 gp120 in mammalian cells.J Virol2025https://conductscience.org/library/papers/41201241PubMed
40990223Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV.J Infect Dis2026https://conductscience.org/library/papers/40990223PubMed
39868926NK Count and Natural Cytotoxicity in Immune Nonresponders Versus Responders Living With HIV.J Med Virol2025https://conductscience.org/library/papers/39868926PubMed
39827271α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia.Nat Commun2025https://conductscience.org/library/papers/39827271PubMed
39373535CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies.mBio2024https://conductscience.org/library/papers/39373535PubMed
39339960New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs.Viruses2024https://conductscience.org/library/papers/39339960PubMed
39233711Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study.Open Forum Infect Dis2024https://conductscience.org/library/papers/39233711PubMed
38756960Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach.JAC Antimicrob Resist2024https://conductscience.org/library/papers/38756960PubMed
38035854
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.
J Infect Dis2024https://conductscience.org/library/papers/38035854PubMed
37957382Viral and host mediators of non-suppressible HIV-1 viremia.Nat Med2023https://conductscience.org/library/papers/37957382PubMed
37954841Current drugs for HIV-1: from challenges to potential in HIV/AIDS.Front Pharmacol2023https://conductscience.org/library/papers/37954841PubMed
37243275Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage.Viruses2023https://conductscience.org/library/papers/37243275PubMed

Download CSV of cited by

Genes33

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKR1C41109PubTator's text mininghttps://conductscience.org/library/genes/1109NCBI Gene
BST2684PubTator's text mininghttps://conductscience.org/library/genes/684NCBI Gene
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CCL206364PubTator's text mininghttps://conductscience.org/library/genes/6364NCBI Gene
CCL36348PubTator's text mininghttps://conductscience.org/library/genes/6348NCBI Gene
CCL46351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CCL56352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL1310563PubTator's text mininghttps://conductscience.org/library/genes/10563NCBI Gene
CXCL22920PubTator's text mininghttps://conductscience.org/library/genes/2920NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
DCTN610671PubTator's text mininghttps://conductscience.org/library/genes/10671NCBI Gene
ENPEP2028PubTator's text mininghttps://conductscience.org/library/genes/2028NCBI Gene
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444NCBI Gene
FURIN5045PubTator's text mininghttps://conductscience.org/library/genes/5045NCBI Gene
HAMP57817PubTator's text mininghttps://conductscience.org/library/genes/57817NCBI Gene

See all 33 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36958337

GET https://conductscience.org/api/papers/v1/36958337/references?page=2